Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells
American Journal of Physiology-Lung Cellular and Molecular Physiology · 2025
DOI: 10.1152/ajplung.00258.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Lung Cellular and Molecular Physiology, 2025. Verfasst von Neerupma Silswal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, U…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Epithelial Cells, Mucociliary Clearance, Smoke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Cystic Fibrosis Foundation (CFF), James and Esther King Florida Biomedical Research Program.
Themen: COPD
Abstract (Originalsprache)
Cigarette smoke (CS) increases transforming growth factor-beta1 (TGF-β1) expression that causes mucociliary dysfunction by decreasing ion channel function. In our study, a CFTR amplifier (nesolicaftor) and angiotensin II receptor blockers (losartan and telmisartan) improve CS-induced ion channel dysfunction, by increasing binding of PCBP1 to CFTR and LRRC26 mRNAs. Therefore, nesolicaftor and ARBs, acting on the same target, may provide therapeutic benefits for treating smoking-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States.
- Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas, United States.
ORCID-Profile: Michael D Kim, Matthias Salathe
Förderung
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- Cystic Fibrosis Foundation (CFF)
- James and Esther King Florida Biomedical Research Program
- Flight Attendant Medical Research Institute (FAMRI)
- NHLBI NIH HHS
Zitieren
APA
Silswal, N., Baumlin, N., Haworth, S., Montgomery, R. N., Yoshida, M., Dennis, J. S., Yerrathota, S., Kim, M. D., & Salathe, M. (2025). Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.00258.2024
Vancouver
Silswal N, Baumlin N, Haworth S, Montgomery RN, Yoshida M, Dennis JS, et al. Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2025. doi:10.1152/ajplung.00258.2024
BibTeX
@article{Silswal2025,
author = {Silswal, Neerupma and Baumlin, Nathalie and Haworth, Steven and Montgomery, Robert N and Yoshida, Makoto and Dennis, John S and Yerrathota, Sireesha and Kim, Michael D and Salathe, Matthias},
title = {Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells},
journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
year = {2025},
doi = {10.1152/ajplung.00258.2024}
}
EUVIMED